DOSSIER · 13F Holders · Q2 2026
ARROWHEAD PHARMACEUTICALS IN
4 institutions still hold ARROWHEAD PHARMACEUTICALS IN as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 04280A950·4 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
4 institutions reported ARROWHEAD PHARMACEUTICALS IN in Q2 2026. IMC-Chicago, LLC leads at 47.6% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.